DA reduces the secretion of prolactin by binding to the dopamine 2 receptor (D2R) in the pituitary tumor, consequently decreasing the tumor volume and lowering the angiogenesis in the surrounding tissue and inducing a tumoricidal effect [18]. The gene discussed is DRD2; the disease is pituitary tumor.